Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 14 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $998K 21.4K sh |
| Nov 4, 2026 traded Nov 3, 2026 |
| 14 | McCulloch KevinSee Remarks | Open-market sale · 10b5-1 plan | SELL | $153K 15.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 14 | Karsanbhai Surendralal LancaDirector, President & CEO | Tax withholding | F | $1.33M 7,999 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 14 | Pieper StevenSee Remarks | Open-market sale · 10b5-1 plan | SELL | $51K 5,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 14 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $595K 11.6K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 14 | Hancock MarkDirector, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $605K 11.8K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 13 | Linnane Robert13D Group Member | Tax withholding | F | $17K 608 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Gordon William BDirector | Open-market sale · 10b5-1 plan | SELL | $97K 700 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $2,717 7 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Lin AlfredDirector | Other acquisition or disposition | J | — 254.4K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Derhacobian NarbehDirector | Option exercise | M | — 8,541 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Stiefel Jennifer D HDirector, President & Secretary | Tax withholding | F | $961 433 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Gordon William BDirector | Open-market sale · 10b5-1 plan | SELL | $240K 1,759 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Zornio PeterChief Technology Officer | Grant or award | A | — 7,547 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Mitra SabyaschiGroup President | Grant or award | A | — 10.6K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Baughman Michael JExec VP, CFO & CAO | Grant or award | A | — 13.8K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Gordon William BDirector | Open-market sale · 10b5-1 plan | SELL | $190K 1,374 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Buch James R.Director | Grant or award | A | — 4,562 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 13 | Swanson Luke RoyCHIEF TECHNOLOGY OFFICER | Open-market sale · 10b5-1 plan | SELL | $31K 470 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 13 | Jensen CoreyDirector | Grant or award | A | — 1,232 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Spaulding MirandaEVP - CFO | Grant or award | A | — 2,429 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Angel Stephen FDirector, President & CEO | Grant or award | A | $9,034 175 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $49K 120 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Stiefel Justin BDirector, CEO & Treasurer | Option exercise | M | — 208 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Utterback Cynthia ADirector | Grant or award | A | — 1,232 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Jordan Joseph HughDirector, Chief Executive Officer | Option exercise · 10b5-1 plan | M | $819K 4,870 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Chandra SunilDirector | Grant or award | A | $32K 550 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 13 | Hooks Michael K.Director | Grant or award | A | — 4,562 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 13 | Brophy Michael BurkesCHIEF FINANCIAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $3,104 8 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Halverson EmilyVP Finance, Controller & Treas | Option exercise | M | — 970 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $35K 662 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 13 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $3,494 9 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Murphy Peter EDirector | Grant or award | A | — 4,562 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 13 | Tang MichaelSr VP, Secy & Chf Leg Ofc | Grant or award | A | — 6,227 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Bidzos D JamesDirector, Exec. Chairman, Pres, & CEO | Open-market sale · 10b5-1 plan | SELL | $201K 640 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 13 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $33K 80 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Train Michael H.SVP & Chief Sustain Officer | Grant or award | A | — 20.1K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Chhina Ivar S.Director | Grant or award | A | — 4,562 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 13 | Bidzos D JamesDirector, Exec. Chairman, Pres, & CEO | Open-market sale · 10b5-1 plan | SELL | $202K 640 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 13 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $49K 120 sh | Nov 4, 2026 traded Nov 2, 2026 |